Brenda Hightower, PMP

Chief Operating Officer at ProBiora Health LLC

Brenda Hightower, PMP, has a diverse work experience spanning over four decades. Brenda began their career at Celanese in 1981 as a Project Manager and worked there for 30 years. In 2011, they transitioned to Haas Group International as a Senior Program Manager, where they stayed until 2018. Following that, they joined Solomon Associates as a Senior Advisor and Project Manager for their Practice Leadership Team from 2018 to 2022. Currently, Brenda holds the position of Chief Operating Officer at ProBiora Health LLC, starting in June 2022.

Brenda Hightower, PMP has a strong educational background in both business administration and mechanical engineering. From 1977 to 1981, they attended Texas A&M University and obtained a Bachelor of Science degree in Mechanical Engineering. Following this, they pursued further education and earned a Master of Business Administration (MBA) degree in Business Administration and Management, General from Texas A&M University between 1985 and 1989.

In addition to their academic qualifications, Brenda has also obtained several certifications throughout their career. In April 2006, they became a Project Management Professional (PMP) after completing the certification program offered by the Project Management Institute. Furthermore, in July 2022, Brenda obtained the NACD Directorship Certification® from the National Association of Corporate Directors.

This combination of academic achievements and professional certifications showcases Brenda Hightower's dedication to continuous learning and their commitment to excelling in their field.

Location

Dallas, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


ProBiora Health LLC

ProBiora Health is bringing the science of probiotics to oral care by developing and marketing a complete line of proprietary probiotics that are specifically designed to enhance oral health for humans and pets. Our products are developed from ProBiora3®, which was discovered by Dr. Jeffrey Hillman on the concept of replacement therapy. ProBiora3® is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3®, Streptococcus uberis KJ2® and Streptococcus rattus JH145®, which support overall oral health. We believe ProBiora3® is the most comprehensive oral care probiotics technology currently available in the oral healthcare market. Starting in 2008, a line of consumer, professional and pet oral products based on Dr. Hillman’s discovery was introduced under the Evora brand name. In 2009, both the EvoraPlus and the EvoraPet product lines were introduced to the consumer market. And in 2010, EvoraPro was introduced to the professional dental care market. In June 2016, the complete line of Evora (ProBiora) consumer, professional and pet products were purchased by ProBiora Health™, which is led by Christine Koski, a former Oragenics board member and longtime investor.


Employees

11-50

Links